Xias Bio Limited

Designing High-Performance Proteins to Empower Innovation and Sustainability

Xias Bio Limited is a biotech company in Glasgow, United Kingdom, founded in 2020. It has raised $4.8M across 1 round, most recently a $4.8M Seed in August 2024.

Headquarters
Glasgow, Scotland
Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$4.8M
Last Round
$4.8M SeedAug 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. to use credits for reveals, or explore the API.

About

Xias Bio is a Scottish biotechnology company developing the LitePlatform™, a modular protein and peptide design system that produces multi-functional, animal-free ingredients using precision fermentation. The platform enables companies across cosmetics, personal care, food, and pharmaceutical sectors to design bespoke proteins — including collagen, keratin, and elastin alternatives — with tunable performance properties. Each LiteProtein™ can replace multiple animal-derived ingredients in a single molecule, reducing reliance on livestock-derived raw materials while meeting consumer and regulatory sustainability demands. Xias Bio also offers R&D services spanning peptide discovery, functional assay development, and biofermentation manufacturing support.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundAug 2024
$4.8M

Investors

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

  • Cloud/Infrastructure ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Xias Bio Limited on Indexed.vc
<a href="https://indexed.vc/companies/xias-bio-limited"><img src="https://indexed.vc/api/badge/company/xias-bio-limited" alt="Xias Bio Limited on Indexed.vc" width="260" height="76" /></a>